Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial

Stroke; a Journal of Cerebral Circulation
C LegaultJ W Hammon

Abstract

We conducted a double-blind, randomized clinical trial in patients undergoing cardiac valve replacement to determine whether nimodipine, a dihydropyridine calcium antagonist, reduced the risk of new neurological, neuro-ophthalmologic, or neuropsychological deficits-common complications associated with cardiac surgery-1 week after surgery. Enrollment for a total of 400 patients started in May 1992 and was stopped in September 1994, with 150 patients randomized to the study. Nimodipine was given to the patients during the perioperative period. Patients underwent examinations before surgery and at approximately 1 week, 1 month, and 6 months after surgery. Major adverse events, including deaths and strokes, were monitored monthly. The trial was terminated early because of both an unexpected disparity in death rates between groups and a lack of evidence of a beneficial effect of nimodipine. New deficits were observed in 72% of the placebo group versus 77% of the nimodipine group (p=.55). In the 6-month follow-up period, 8 deaths (10.7%) occurred in the nimodipine group (n=75) compared with 1 death (1.3) in the placebo group (n=74) (p=.02). Major bleeding occurred in 10 patients in the nimodipine group versus 3 in the placebo group (...Continue Reading

References

Oct 1, 1990·Annals of Neurology·D M MoodyD S Prough
Sep 1, 1985·British Journal of Clinical Pharmacology·C R JonesJ L Reid
Dec 1, 1985·The Annals of Thoracic Surgery·T J GardnerB A Reitz
Apr 14, 1982·Biochemical and Biophysical Research Communications·P M EpsteinD M Andrenyak
Dec 15, 1982·Thrombosis Research·G DavìA Strano
Feb 1, 1983·The American Journal of Cardiology·C W PumphreyM P Kaye
Mar 25, 1995·BMJ : British Medical Journal·L E WagenknechtB T Troost
Jan 1, 1995·American Journal of Therapeutics·Sergey E. Akopov, Movses A. Sarkisian

❮ Previous
Next ❯

Citations

Jun 14, 2008·Der Anaesthesist·M J Merkel, A M Brambrink
Nov 28, 2001·The Annals of Thoracic Surgery·J M Murkin
May 13, 1999·The Annals of Thoracic Surgery·S J MitchellD F Gorman
Mar 6, 2004·The Journal of Thoracic and Cardiovascular Surgery·Duminda N WijeysunderaKeyvan Karkouti
Mar 17, 2004·Journal of Clinical Epidemiology·M GalleraniUNKNOWN Investigators of the GIFA Study (Gruppo Italiano di Farmacovigilanza nell'Anziano)
Sep 1, 1999·Journal of Cardiothoracic and Vascular Anesthesia·G Mychaskiw, P Hoehner
Dec 10, 2013·British Journal of Anaesthesia·F BilottaG Rosa
Mar 12, 1998·Anesthesia and Analgesia·J F ButterworthJ W Hammon
Jun 23, 2006·Anesthesia and Analgesia·Charles W HogueJoseph E Arrowsmith
Jan 5, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·H TomiyamaN Doba
Dec 19, 2013·PloS One·Arianna GhirardiUNKNOWN BEST Investigators
Jun 23, 1999·Seminars in Thoracic and Cardiovascular Surgery·C W HogueV G Dávila-Román
Oct 3, 2002·Journal of Neurosurgical Anesthesiology·Gina MateiIra S Kass
May 13, 1999·Anesthesiology·B J Hindman, M M Todd
Mar 13, 2012·Hospital Practice·Christoph S Burkhart, Luzius A Steiner
Jun 2, 2005·Expert Opinion on Investigational Drugs·Valentin K Gribkoff, Raymond J Winquist
May 18, 2010·Journal of Cardiothoracic and Vascular Anesthesia·Marina SvyatetsJean Charchaflieh
Apr 14, 2007·Clinics in Podiatric Medicine and Surgery·Bruce I KaczanderGurbir S Mann
May 17, 2005·Journal of Thrombosis and Haemostasis : JTH·I J WelsbyUNKNOWN Perioperative Genetics and Safety Outcomes Study (PEGASUS) Investigative Team
Dec 17, 2003·Acta Anaesthesiologica Scandinavica·J Ahonen, M Salmenperä
Sep 6, 2007·The Journal of Clinical Hypertension·Domenic A Sica, Rosemarie Mannino
Nov 29, 2013·The Journal of Clinical Hypertension·William PhillipsUNKNOWN ALLHAT Collaborative Research Group
Nov 5, 1997·Journal of Cardiothoracic and Vascular Anesthesia·A Rogers
Oct 18, 2003·Anesthesiology Clinics of North America·Hilary P Grocott, Nancy A Nussmeier
Jan 3, 2001·The Journal of Thoracic and Cardiovascular Surgery·M J NevilleD A Stump
Mar 28, 2007·Asian Cardiovascular & Thoracic Annals·Yuji Kadoi
May 9, 2007·Seminars in Cardiothoracic and Vascular Anesthesia·Ihab DorottaRichard Applegate
May 28, 2005·Seminars in Cardiothoracic and Vascular Anesthesia·Kriengchai Prasongsukarn, Michael A Borger
May 1, 1997·Anesthesia and Analgesia·N WangR Perryman
May 18, 2012·The Cochrane Database of Systematic Reviews·Jing ZhangMing Liu
Feb 14, 2019·The Cochrane Database of Systematic Reviews·Jing ZhangMing Liu
May 19, 2010·Seminars in Cardiothoracic and Vascular Anesthesia·Walter M van den Bergh
Mar 15, 2019·Anesthesiology·Rebecca Y KlingerUNKNOWN Neurologic Outcomes Research Group of the Duke Heart Center
Oct 29, 2002·Anesthesia and Analgesia·John Butterworth, John W Hammon
Sep 29, 2019·Current Neuropharmacology·Andrew P CarlsonClaude W Shuttleworth
Mar 10, 2020·Interventional Medicine & Applied Science·Daniel G JovinBenita Dharmaraj

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.